文献速递儿科影像腹部技术与安全US

撒哈拉以南非洲儿童肠套叠非手术治疗的疗效与安全性:系统评价与荟萃分析

Efficacy and safety of nonoperative management for pediatric intussusception in Sub-Saharan Africa: a systematic review and meta-analysis.
PubMed 文献 · Pediatr Radiol · 2025-11-22

该系统评价与荟萃分析纳入撒哈拉以南非洲9项研究共536例儿童肠套叠患者,评估非手术复位(主要为超声引导下灌肠复位)的疗效与安全性。汇总成功率为78%(95%CI 71-86%;I²=78.6%),失败率22%,穿孔率3%(95%CI 0-6%),复发率7%(95%CI 3-12%),报告1例操作相关死亡。延误就诊、病理性引导点和多普勒血流信号缺失是失败的一致预测因素。

要点

  • 儿童肠套叠非手术复位汇总成功率为78%(95%CI 71-86%;I²=78.6%),失败率22%。
  • 穿孔率3%(95%CI 0-6%),复发率7%(95%CI 3-12%),报告1例操作相关死亡。
  • 延误就诊、病理性引导点和多普勒血流信号缺失是非手术复位失败的一致预测因素。

核心结论

  • 在撒哈拉以南非洲,儿童肠套叠非手术复位有效且安全,近年结局有所改善,尤其在使用超声引导的情况下;延误就诊仍是成功的主要障碍。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Scopus、Web of Science、African Journals Online和Google Scholar从建库至2025年3月,纳入9项研究共536例患者,采用纽卡斯尔-渥太华量表评估研究质量,随机效应模型进行荟萃分析,GRADE框架评估证据确定性。

关键影像表现/征象

  • 多普勒血流信号缺失是非手术复位失败的一致预测因素。
  • 病理性引导点是非手术复位失败的一致预测因素。
  • 延误就诊是非手术复位失败的一致预测因素。
  • 汇总男性患病率为67%(95%CI 60-74%),平均年龄范围为2.8个月至21个月。

诊断标准与关键数值

  • 非手术复位总体成功率为78%(95%CI 71-86%;I²=78.6%),失败率为22%。
  • 2022年后发表的研究成功率≥81.6%,高于更早报告的≤73.1%。
  • 汇总穿孔率为3%(95%CI 0-6%),报告1例操作相关死亡。
  • 复发率为7%(95%CI 3-12%)。
  • 证据确定性:性别患病率为中等,成功/失败为低,并发症、复发和死亡为低至极低。

临床应用与阅片要点

  • 非手术复位可作为儿童肠套叠的首选处理方式,尤其在超声引导下进行。
  • 延误就诊、病理性引导点和多普勒血流信号缺失提示非手术复位失败风险较高。
  • 扩大影像学可及性、加强转诊系统并规范报告有助于改善该地区的结局和证据质量。

局限性

  • 成功/失败结局的证据确定性为低。
  • 并发症、复发和死亡结局的证据确定性为低至极低。
  • 成功率的异质性I²=78.6%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Intussusception, a serious condition where the intestine folds in on itself, is a leading cause of bowel obstructions in children. The global standard of care has shifted towards non-surgical procedures as a first response. However, evidence supporting the effectiveness and safety of this approach specifically within Sub-Saharan Africa has been scarce and disjointed. Our research systematically gathered and analyzed the existing data from the region to provide a clearer assessment.

METHODS: We searched PubMed, Scopus, Web of Science, African Journals Online, and Google Scholar from inception (earliest date covered by each database) to March 2025 for studies reporting outcomes of non-operative reduction in children with intussusception in Sub-Saharan Africa. Eligible studies focused primarily on non-operative reduction with clearly reported outcomes. Data were extracted independently by two reviewers, and study quality was assessed using the Newcastle-Ottawa Scale. Meta-analyses were performed using random-effects models for sex distribution and treatment outcomes, while complications, recurrence, and mortality were synthesized narratively. Certainty of evidence was evaluated using the GRADE framework.

RESULTS: Nine studies including 536 patients met the inclusion criteria. The pooled male prevalence was 67% (95%CI 60-74%), and the mean age ranged from 2.8 months to 21 months. The overall success rate of non-operative reduction was 78% (95%CI 71-86%; I2 = 78.6%), while the failure rate was 22%. Success rates were higher in studies published after 2022 (≥81.6%) compared to earlier reports (≤73.1%). The pooled perforation rate was 3% (95%CI 0-6%), with a single procedure-related mortality reported. Recurrence occurred in 7% (95%CI 3-12%) of patients. Delayed presentation, pathological lead points, and absent Doppler flow were consistent predictors of failure. Certainty of evidence was moderate for sex prevalence, low for success/failure, and low to very low for complications, recurrence, and mortality.

CONCLUSION: Non-operative reduction of pediatric intussusception in Sub-Saharan Africa is effective and safe, with outcomes improving in recent years, particularly with ultrasound guidance. Delayed presentation remains the major barrier to success. Expanding access to imaging, strengthening referral systems, and standardizing reporting are essential to improve outcomes and evidence quality in the region.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Molla YD, Setargew KH, Alemu HT, et al. Efficacy and safety of nonoperative management for pediatric intussusception in Sub-Saharan Africa: a systematic review and meta-analysis. Pediatr Radiol. 2025. PMID: 41273412. doi:10.1007/s00247-025-06474-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。